I

Innova Captab Ltd
NSE:INNOVACAP

Watchlist Manager
Innova Captab Ltd
NSE:INNOVACAP
Watchlist
Price: 1 015 INR -2.58% Market Closed
Market Cap: 58.1B INR
Have any thoughts about
Innova Captab Ltd?
Write Note

Innova Captab Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Innova Captab Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
I
Innova Captab Ltd
NSE:INNOVACAP
Accounts Receivables
â‚ą2.9B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Accounts Receivables
â‚ą21.6B
CAGR 3-Years
9%
CAGR 5-Years
323%
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Accounts Receivables
â‚ą38.9m
CAGR 3-Years
32%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Accounts Receivables
â‚ą7.1B
CAGR 3-Years
26%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Accounts Receivables
â‚ą4.8B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Tarsons Products Ltd
NSE:TARSONS
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Innova Captab Ltd
Glance View

Market Cap
58.1B INR
Industry
Life Sciences Tools & Services

Innova Captab Ltd is a IN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Panchkula, Haryana. The company went IPO on 2023-12-29. Innova Captab Ltd is an integrated pharmaceutical company. The firm is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company has presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes CDMO business, domestic branded generics business, and international branded generic product business. Its CDMO business provides research, product development and manufacturing services. Its branded generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. The company has developed a diversified branded generics product portfolio including Tablets, capsules, dry syrups, dry powder injection, ointments and liquid orals.

INNOVACAP Intrinsic Value
781.94 INR
Overvaluation 23%
Intrinsic Value
Price
I

See Also

What is Innova Captab Ltd's Accounts Receivables?
Accounts Receivables
2.9B INR

Based on the financial report for Mar 31, 2024, Innova Captab Ltd's Accounts Receivables amounts to 2.9B INR.

What is Innova Captab Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
28%

Over the last year, the Accounts Receivables growth was 9%. The average annual Accounts Receivables growth rates for Innova Captab Ltd have been 28% over the past three years .

Back to Top